# Anyeep

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/anyeep

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.anyeep.com/
- Total disclosed funding: $28M
- Latest round: Series B (Dec 5, 2025)
- Investors on record: 7

## About

Founded in 2021 and based in Suzhou, China, Anyeep (Suzhou) Medical Technology Co., Ltd., trading under the name Anyeep, develops chemical analysis and medical testing instruments for the medical devices and equipment sector. The company focuses on mass spectrometry technologies across laboratory, applied and portable formats. Its instruments are used by clinical institutions, research organizations and industrial users in China. The firm completed its liquid triple quadrupole system TQ9100 in 2022. In December 2025, Anyeep raised approximately CNY 100 million in series B funding co-led by Green Pine Capital Partners and BioTrack Capital, with participation from returning investor YuanBio Venture.

The company works with institutional, clinical and industrial clients to provide mass spectrometry products used for chemical analysis and medical testing. Its offerings include applied mass spectrometers, laboratory instruments and portable systems supporting neonatal metabolic screening, vitamin analysis, drug concentration monitoring, hormone testing, microbial identification, pharmacogenomic studies and food and environmental contaminant analysis.

The company’s revenue is generated through B2B sales of chemical analysis and medical testing machines. 

The company plans to enhance the performance and production capacity of its mass spectrometry products and expand their application and market reach in scientific research, clinical diagnostics, regulatory testing and industrial sectors.

## Funding rounds

- Series B, Dec 5, 2025, $14M — Green Pine Capital Partners, YuanBio Venture, BioTrack Capital
- Series A, Nov 25, 2022, $14M — YuanBio Venture, Greenriver Capital, Honest Capital, Peakvest Investment, Frees Fund

## Investors

- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series A, Series B
- Greenriver Capital (https://capitalatlas.ai/funds/greenriver-capital) — Series A
- Honest Capital (https://capitalatlas.ai/funds/honest-capital) — Series A
- Peakvest Investment — Series A
- Frees Fund (https://capitalatlas.ai/funds/frees-fund) — Series A
- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Series B
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Series B